about
Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerationsQuantification of the Serotonin 1A Receptor Using PET: Identification of a Potential Biomarker of Major Depression in MalesOmega-3 polyunsaturated fatty acid supplementation and white matter changes in major depression.Relationship of the serotonin transporter gene promoter polymorphism (5-HTTLPR) genotype and serotonin transporter binding to neural processing of negative emotional stimuli.Short-term Effects of Risperidone Monotherapy on Spontaneous Brain Activity in First-episode Treatment-naïve Schizophrenia Patients: A Longitudinal fMRI Study.Positron Emission Tomographic Imaging of the Serotonergic System and Prediction of Risk and Lethality of Future Suicidal Behavior.Lack of association between the serotonin transporter and serotonin 1A receptor: an in vivo PET imaging study in healthy adultsUtility of Molecular and Structural Brain Imaging to Predict Progression from Mild Cognitive Impairment to Dementia.White matter correlates of impaired attention control in major depressive disorder and healthy volunteers.Pattern recognition of magnetic resonance imaging-based gray matter volume measurements classifies bipolar disorder and major depressive disorder.Longitudinal effects of cognitive behavioral therapy for depression on the neural correlates of emotion regulation.A positron emission tomography study of the serotonergic system in relation to anxiety in depression.Kappa opioid receptor binding in major depression: A pilot studyIn vivo relationship between serotonin 1A receptor binding and gray matter volume in the healthy brain and in major depressive disorderNegative Autobiographical Memory in Depression Reflects Elevated Amygdala-Hippocampal Reactivity and Hippocampally Associated Emotion RegulationAntidepressant medication exposure and 5-HT1A autoreceptor binding in major depressive disorderDepression-related anterior cingulate prefrontal resting state connectivity normalizes following cognitive behavioral therapy
P50
Q33976272-F037DAF4-8E30-4149-AE6A-AA15FAABE826Q37024830-25ECFEB3-3BC3-461D-AFBE-1C5B74F26843Q37103529-EFB51623-4471-425B-8240-A1D477349145Q37252773-81DA3228-D1DD-4941-9B60-FA39ACF938D1Q37307572-97DF33B3-EB41-42DB-8BAC-375571ECA2EEQ38837345-99B2AC94-2A35-4FBB-940D-C491F0C2990DQ39447750-1248441E-5E4F-4900-8BFF-F0E302DFB05FQ46133238-93993ECF-0988-4591-8CE2-5CB4D3B89F45Q46445549-6324A46C-DEFA-490A-A34E-BB3C83CD3FDFQ47442729-70A1E1B9-6E12-4A18-BFC9-B09B4CA44BF7Q47711544-FC524327-EE70-45DA-B08B-E8B62932F911Q47724853-6F9E5F87-D41F-4768-9741-C71E8D9F3DCDQ57166284-19F55300-9668-4BE5-AA6B-60A2CAA69302Q88089709-7FA421BB-797A-434A-AA08-8E066822B9EFQ88300849-A3510995-D1F3-4C47-BAB8-700C5A74FD1DQ91262262-2469A015-D3A5-4642-91F4-94310EFBF292Q91871430-326E0004-D444-44F3-BE07-D7990F539456
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jeffrey M Miller
@ast
Jeffrey M Miller
@en
Jeffrey M Miller
@es
Jeffrey M Miller
@nl
type
label
Jeffrey M Miller
@ast
Jeffrey M Miller
@en
Jeffrey M Miller
@es
Jeffrey M Miller
@nl
prefLabel
Jeffrey M Miller
@ast
Jeffrey M Miller
@en
Jeffrey M Miller
@es
Jeffrey M Miller
@nl
P106
P31
P496
0000-0002-2206-9311